Jeffrey M Lemons, MD Radiology - Radiation Oncology Medicare: Accepting Medicare Assignments Practice Location: 789 Central Ave, Dover, NH 03820 Phone: 603-742-8787 Fax: 603-840-2637 |
Arul Mahadevan, MD Radiology - Radiation Oncology Medicare: Accepting Medicare Assignments Practice Location: 789 Central Ave, Seacost Cancer Center, Dover, NH 03820 Phone: 603-742-8787 Fax: 603-740-2637 |
Dr. Jeffrey Vincent Brower, M.D., PH.D. Radiology - Radiation Oncology Medicare: Accepting Medicare Assignments Practice Location: 789 Central Ave, Dover, NH 03820 Phone: 603-742-8787 Fax: 603-740-2637 |
Dr. Asa Joel Nixon, M.D., M.P.H. Radiology - Radiation Oncology Medicare: Accepting Medicare Assignments Practice Location: 789 Central Ave, Dover, NH 03820 Phone: 603-742-8787 |
Su Kyong Metcalfe, M.D., M.P.H. Radiology - Radiation Oncology Medicare: Accepting Medicare Assignments Practice Location: 789 Central Ave, Dover, NH 03820 Phone: 603-742-8787 |
Dr. Himanshu Singh, MD Radiology - Radiation Oncology Medicare: Accepting Medicare Assignments Practice Location: 789 Central Ave, Wentworth Douglass Hospital, Dover, NH 03820 Phone: 603-742-8787 |
News Archive
A literature review, led by Dr. Joseph Lee, published in the June 2010 issue of the Journal of the American Academy of Orthopaedic Surgeons (JAAOS) suggests that a herniated disk is one of the most frequent causes of low back and leg pain in adults, but surgery is not for everyone. Between 60 and 80 percent of people will experience low back pain at some point in their lives.
New treatments are offering the prospect of eating without fear for the 15 million people in the United States with food allergies, according to the cover story in the current issue of Chemical & Engineering News.
In overweight and obese children and adolescents, vitamin D deficiency is associated with early markers of cardiovascular disease, a new study reports. The research results will be presented Sunday, April 2, at ENDO 2017, the annual scientific meeting of the Endocrine Society, in Orlando.
MSD announced today that the European Commission has approved the Marketing Authorization Application (MAA) for SYCREST® (asenapine) sublingual tablets for the treatment of moderate to severe manic episodes associated with bipolar I disorder in adults. Today's decision was based on recommendations from the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP). The Commission Decision applies to all 27 European Member States.
A new study from the Center for Disease Dynamics, Economics & Policy, with collaborators from Johns Hopkins University and University of Texas Southwestern Medical Center, found that infections caused by one of the most common drug resistant bacteria in the US-methicillin-resistant Staphylococcus aureus, known as MRSA-are no more expensive to treat than MSSA, the methicillin-susceptible version of the same bacteria.
› Verified 9 days ago